Compounds > artemisinin
Page last updated: 2024-08-25

artemisinin and Neglected Diseases

artemisinin has been researched along with Neglected Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amendola, G; Chouchene, K; Cosconati, S; Ettari, R; Grasso, S; Gut, J; Hellmich, UA; Krauth-Siegel, RL; Previti, S; Rosenthal, PJ; Schirmeister, T; Schmid, I; Ulrich, K; Wagner, A; Wich, PR; Zappalà, M1
Stokstad, E; Vogel, G1
Maxmen, A1

Other Studies

3 other study(ies) available for artemisinin and Neglected Diseases

ArticleYear
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
    Journal of medicinal chemistry, 2017, 08-24, Volume: 60, Issue:16

    Topics: Antimalarials; Carbamates; Cathepsin L; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dipeptides; HeLa Cells; Humans; Hydrogen Bonding; Malaria; Molecular Docking Simulation; Molecular Dynamics Simulation; Neglected Diseases; Phenylalanine; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African

2017
NOBEL PRIZES. Neglected tropical diseases get the limelight in Stockholm.
    Science (New York, N.Y.), 2015, Oct-09, Volume: 350, Issue:6257

    Topics: Antimalarials; Artemisinins; China; Humans; Malaria; Medicine, Chinese Traditional; Neglected Diseases; Nobel Prize; Onchocerciasis, Ocular; Tropical Medicine

2015
Busting the billion-dollar myth: how to slash the cost of drug development.
    Nature, 2016, 08-25, Volume: 536, Issue:7617

    Topics: Africa; Amodiaquine; Anti-Bacterial Agents; Artemisinins; Benzamides; Boron Compounds; Child; Clinical Trials as Topic; Cooperative Behavior; Developed Countries; Developing Countries; Drug Approval; Drug Combinations; Drug Costs; Drug Discovery; Drug Industry; Drug Repositioning; Drug Resistance, Microbial; Female; Humans; Malaria; Neglected Diseases; Negotiating; Nitroimidazoles; Organizations, Nonprofit; Sample Size; Trypanosomiasis, African; World Health Organization

2016